Distinguishing Pathovars from Nonpathovars: Escherichia coli.
Riley LW.
Microbiol Spectr. 2020 Dec;8(4):10.1128/microbiolspec.ame-0014-2020. doi: 10.1128/microbiolspec.AME-0014-2020.
Escherichia coli bacteraemia.
OWEN T, SPAULDING WB.
Can Med Assoc J. 1956 Dec 15;75(12):1020-4.
Escherichia coli--an overview.
Cooke EM.
J Hyg (Lond). 1985 Dec;95(3):523-30. doi: 10.1017/s022217240006065x.
Proteomics of septicemic Escherichia coli.
Otto A, Biran D, Sura T, Becher D, Ron EZ.
Proteomics Clin Appl. 2016 Oct;10(9-10):1020-1024. doi: 10.1002/prca.201600049.
Escherichia coli sequence type 131: epidemiology and challenges in treatment.
Qureshi ZA, Doi Y.
Expert Rev Anti Infect Ther. 2014 May;12(5):597-609. doi: 10.1586/14787210.2014.899901. Epub 2014 Apr 2.
What makes Escherichia coli pathogenic?
Siitonen A.
Ann Med. 1994 Aug;26(4):229-31. doi: 10.3109/07853899409147895.
Clonality and virulence traits of Escherichia coli associated with haemorrhagic septicaemia in turkeys.
Olsen RH, Chadfield MS, Christensen JP, Scheutz F, Christensen H, Bisgaard M.
Avian Pathol. 2011 Dec;40(6):587-95. doi: 10.1080/03079457.2011.618942.
Neonatal septicaemia caused by diverse clones of Klebsiella pneumoniae & Escherichia coli harbouring blaCTX-M-15.
Roy S, Gaind R, Chellani H, Mohanty S, Datta S, Singh AK, Basu S.
Indian J Med Res. 2013 Apr;137(4):791-9.
Colisepticaemia of lambs.
Mason RW, Corbould A.
Aust Vet J. 1981 Oct;57(10):458-60. doi: 10.1111/j.1751-0813.1981.tb05765.x.
Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility.
Roy S, Datta S, Viswanathan R, Singh AK, Basu S.
J Antimicrob Chemother. 2013 May;68(5):1036-42. doi: 10.1093/jac/dks535. Epub 2013 Jan 18.
